Skip to content

A study to assess the impact of the pneumococcal conjugate vaccination programme on carriage of pneumococci in children eligible for vaccination and their household contacts

A cross-sectional community-based study to assess the impact of pneumococcal conjugate vaccination programme on the carriage of pneumococci in children eligible for vaccination and their household contacts

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN05935832
Enrollment
200
Registered
2012-02-02
Start date
2012-03-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Pneumococcal Disease Infections and Infestations Streptococcal infection, unspecified site

Interventions

Participating General Practitioners (GP) in Hertfordshire and Gloucestershire in the UK will identify potential participants and provide parents/legal guardians with an information pack about the stud

Sponsors

Health Protection Agency (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least one child aged 1 to 5 years in the household 2. Written informed consent obtained for the child's parent/legal guardian and participating household contacts

Exclusion criteria

Exclusion criteria: 1. Moderate to severe cerebral palsy or other debilitating condition 2. Syndromes and neurological disorders affecting swallowing 3. Ear, nose & throat disorders affecting local anatomy for swabbing (e.g. malformed ears) 4. Confirmed or suspected immunodeficiency (congenital or acquired) or on immunosuppressive therapy

Design outcomes

Primary

MeasureTime frame
1. Pneumococcal carriage rates for PCV13 and non-PCV13 serotypes in children aged 20 years) two years after the introduction of PCV13 3. Invasiveness of any emerging replacement carriage serotypes by estimating case: carrier ratio (CCR) using national surveillance data for invasive pneumococcal disease

Secondary

MeasureTime frame
1. Carriage rates of individual serotypes 2. Compare carriage by PCV7/PCV13 vaccination status in vaccine eligible cohorts 3. Compare, by age-group, changes in carriage serotypes with previous carriage studies performed by the HPA in 2001/02 and 2008/09 in children and adults

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026